{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T01:01:08Z","timestamp":1789174868033,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T00:00:00Z","timestamp":1558051200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T00:00:00Z","timestamp":1558051200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1038\/s41390-019-0408-6","type":"journal-article","created":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T05:05:24Z","timestamp":1558069524000},"page":"444-451","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Repurposing azithromycin for neonatal neuroprotection"],"prefix":"10.1038","volume":"86","author":[{"given":"John D. E.","family":"Barks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjunath P.","family":"Pai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faye S.","family":"Silverstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,17]]},"reference":[{"issue":"Pt 1","key":"408_CR1","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.expneurol.2015.10.012","volume":"275","author":"D Amantea","year":"2016","unstructured":"Amantea, D. et al. Azithromycin protects mice against ischemic stroke injury by promoting macrophage transition towards M2 phenotype. Exp. Neurol. 275(Pt 1), 116\u2013125 (2016).","journal-title":"Exp. Neurol."},{"key":"408_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/srep40144","volume":"7","author":"JC Gensel","year":"2017","unstructured":"Gensel, J. C., Kopper, T. J., Zhang, B., Orr, M. B. & Bailey, W. M. Predictive screening of M1 and M2 macrophages reveals the immunomodulatory effectiveness of post spinal cord injury azithromycin treatment. Sci. Rep. 7, 40144 (2017).","journal-title":"Sci. Rep."},{"key":"408_CR3","first-page":"e811","volume":"212","author":"AL Sutton","year":"2015","unstructured":"Sutton, A. L. et al. Perinatal pharmacokinetics of azithromycin for cesarean prophylaxis. Am. J. Obstet. Gynecol. 212, e811\u2013e816 (2015).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"408_CR4","doi-asserted-by":"publisher","first-page":"6581","DOI":"10.1128\/AAC.03721-14","volume":"58","author":"MW Kemp","year":"2014","unstructured":"Kemp, M. W. et al. Maternal intravenous administration of azithromycin results in significant fetal uptake in a sheep model of second trimester pregnancy. Antimicrob. Agents Chemother. 58, 6581\u20136591 (2014).\u00a0","journal-title":"Antimicrob. Agents Chemother."},{"key":"408_CR5","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1056\/NEJMoa1602044","volume":"375","author":"AT Tita","year":"2016","unstructured":"Tita, A. T. et al. Adjunctive azithromycin prophylaxis for cesarean delivery. N. Engl. J. Med. 375, 1231\u20131241 (2016).","journal-title":"N. Engl. J. Med."},{"key":"408_CR6","doi-asserted-by":"publisher","first-page":"e20162281","DOI":"10.1542\/peds.2016-2281","volume":"139","author":"C Oluwalana","year":"2017","unstructured":"Oluwalana, C. et al. Azithromycin in labor lowers clinical infections in mothers and newborns: a double-blind trial. Pediatrics 139, e20162281 (2017).","journal-title":"Pediatrics"},{"key":"408_CR7","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1128\/AAC.02183-12","volume":"57","author":"RM Viscardi","year":"2013","unstructured":"Viscardi, R. M. et al. Azithromycin to prevent bronchopulmonary dysplasia in ureaplasma-infected preterm infants: pharmacokinetics, safety, microbial response, and clinical outcomes with a 20-milligram-per-kilogram single intravenous dose. Antimicrob. Agents Chemother. 57, 2127\u20132133 (2013).","journal-title":"Antimicrob. Agents Chemother."},{"key":"408_CR8","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1128\/AAC.03951-14","volume":"59","author":"LM Merchan","year":"2015","unstructured":"Merchan, L. M. et al. Pharmacokinetics, microbial response, and pulmonary outcomes of multidose intravenous azithromycin in preterm infants at risk for ureaplasma respiratory colonization. Antimicrob. Agents Chemother. 59, 570\u2013578 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"408_CR9","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.expneurol.2014.01.003","volume":"254","author":"AL Smith","year":"2014","unstructured":"Smith, A. L., Alexander, M., Rosenkrantz, T. S., Sadek, M. L. & Fitch, R. H. Sex differences in behavioral outcome following neonatal hypoxia ischemia: insights from a clinical meta-analysis and a rodent model of induced hypoxic ischemic brain injury. Exp. Neurol. 254, 54\u201367 (2014).","journal-title":"Exp. Neurol."},{"key":"408_CR10","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.neuroscience.2013.12.023","volume":"260","author":"R Chavez-Valdez","year":"2014","unstructured":"Chavez-Valdez, R., Martin, L. J., Razdan, S., Gauda, E. B. & Northington, F. J. Sexual dimorphism in BDNF signaling after neonatal hypoxia-ischemia and treatment with necrostatin-1. Neuroscience 260, 106\u2013119 (2014).","journal-title":"Neuroscience"},{"key":"408_CR11","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/0165-0270(90)90131-X","volume":"35","author":"P Andine","year":"1990","unstructured":"Andine, P. et al. Evaluation of brain damage in a rat model of neonatal hypoxic-ischemia. J. Neurosci. Methods 35, 253\u2013260 (1990).","journal-title":"J. Neurosci. Methods"},{"key":"408_CR12","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1177\/0271678X15624934","volume":"37","author":"JD Barks","year":"2017","unstructured":"Barks, J. D. et al. Maternal high-fat diet influences outcomes after neonatal hypoxic-ischemic brain injury in rodents. J. Cereb. Blood Flow Metab. 37, 307\u2013318 (2017).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"408_CR13","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/pr.2015.100","volume":"78","author":"SD Patel","year":"2015","unstructured":"Patel, S. D. et al. Therapeutic hypothermia and hypoxia-ischemia in the term-equivalent neonatal rat: characterization of a translational preclinical model. Pediatr. Res. 78, 264\u2013271 (2015).","journal-title":"Pediatr. Res."},{"key":"408_CR14","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/pr.2017.266","volume":"83","author":"S Krishna","year":"2018","unstructured":"Krishna, S., Hutton, A., Aronowitz, E., Moore, H. & Vannucci, S. J. The effects of adding prophylactic phenobarbital to therapeutic hypothermia in the term-equivalent hypoxic-ischemic rat. Pediatr. Res. 83, 506\u2013513 (2018).","journal-title":"Pediatr. Res."},{"key":"408_CR15","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1159\/000069053","volume":"24","author":"BT Felt","year":"2002","unstructured":"Felt, B. T. et al. Early appearance of functional deficits after neonatal excitotoxic and hypoxic-ischemic injury: fragile recovery after development and role of the NMDA receptor. Dev. Neurosci. 24, 418\u2013425 (2002).","journal-title":"Dev. Neurosci."},{"key":"408_CR16","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1097\/FTD.0b013e31825c4ba6","volume":"34","author":"MN Neely","year":"2012","unstructured":"Neely, M. N., van Guilder, M. G., Yamada, W. M., Schumitzky, A. & Jelliffe, R. W. Accurate detection of outliers and subpopulations with Pmetrics, a nonparametric and parametric pharmacometric modeling and simulation package for R. Ther. Drug Monit. 34, 467\u2013476 (2012).","journal-title":"Ther. Drug Monit."},{"key":"408_CR17","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1067\/mob.2003.141","volume":"188","author":"PS Ramsey","year":"2003","unstructured":"Ramsey, P. S., Vaules, M. B., Vasdev, G. M., Andrews, W. W. & Ramin, K. D. Maternal and transplacental pharmacokinetics of azithromycin. Am. J. Obstet. Gynecol. 188, 714\u2013718 (2003).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"408_CR18","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1128\/AAC.02668-15","volume":"60","author":"S Salman","year":"2015","unstructured":"Salman, S. et al. Pharmacokinetics of transfer of azithromycin into the breast milk of African mothers. Antimicrob. Agents Chemother. 60, 1592\u20131599 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"408_CR19","doi-asserted-by":"publisher","first-page":"e561","DOI":"10.1016\/j.cmi.2016.03.005","volume":"22","author":"A Roca","year":"2016","unstructured":"Roca, A. et al. Oral azithromycin given during labour decreases bacterial carriage in the mothers and their offspring: a double-blind randomized trial. Clin. Microbiol. Infect. 22, e561\u2013e569 (2016).","journal-title":"Clin. Microbiol. Infect."},{"key":"408_CR20","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/jac\/34.1.111","volume":"34","author":"JL Dumas","year":"1994","unstructured":"Dumas, J. L. et al. Evaluation of the efficacy of prolonged administration of azithromycin in a murine model of chronic toxoplasmosis. J. Antimicrob. Chemother. 34, 111\u2013118 (1994).","journal-title":"J. Antimicrob. Chemother."},{"issue":"Suppl A","key":"408_CR21","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1093\/jac\/25.suppl_A.73","volume":"25","author":"G Foulds","year":"1990","unstructured":"Foulds, G., Shepard, R. M. & Johnson, R. B. The pharmacokinetics of azithromycin in human serum and tissues. J. Antimicrob. Chemother. 25(Suppl A), 73\u201382 (1990).","journal-title":"J. Antimicrob. Chemother."},{"key":"408_CR22","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1128\/AAC.40.3.825","volume":"40","author":"S Jaruratanasirikul","year":"1996","unstructured":"Jaruratanasirikul, S., Hortiwakul, R., Tantisarasart, T., Phuenpathom, N. & Tussanasunthornwong, S. Distribution of azithromycin into brain tissue, cerebrospinal fluid, and aqueous humor of the eye. Antimicrob. Agents Chemother. 40, 825\u2013826 (1996).","journal-title":"Antimicrob. Agents Chemother."},{"issue":"Suppl A","key":"408_CR23","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/jac\/25.suppl_A.49","volume":"25","author":"RM Shepard","year":"1990","unstructured":"Shepard, R. M. & Falkner, F. C. Pharmacokinetics of azithromycin in rats and dogs. J. Antimicrob. Chemother. 25(Suppl A), 49\u201360 (1990).","journal-title":"J. Antimicrob. Chemother."},{"key":"408_CR24","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/bdd.2510120704","volume":"12","author":"D Davila","year":"1991","unstructured":"Davila, D., Kolacny-Babic, L. & Plavsic, F. Pharmacokinetics of azithromycin after single oral dosing of experimental animals. Biopharm. Drug Dispos. 12, 505\u2013514 (1991).","journal-title":"Biopharm. Drug Dispos."},{"key":"408_CR25","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1203\/00006450-199601000-00006","volume":"39","author":"JA Ivacko","year":"1996","unstructured":"Ivacko, J. A., Sun, R. & Silverstein, F. S. Hypoxic-ischemic brain injury induces an acute microglial reaction in perinatal rats. Pediatr. Res. 39, 39\u201347 (1996).","journal-title":"Pediatr. Res."},{"key":"408_CR26","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0197-0186(94)90066-3","volume":"25","author":"D Giulian","year":"1994","unstructured":"Giulian, D., Li, J., Leara, B. & Keenen, C. Phagocytic microglia release cytokines and cytotoxins that regulate the survival of astrocytes and neurons in culture. Neurochem. Int. 25, 227\u2013233 (1994).","journal-title":"Neurochem. Int."},{"key":"408_CR27","doi-asserted-by":"publisher","first-page":"12992","DOI":"10.1523\/JNEUROSCI.2102-11.2011","volume":"31","author":"JV Faustino","year":"2011","unstructured":"Faustino, J. V. et al. Microglial cells contribute to endogenous brain defenses after acute neonatal focal stroke. J. Neurosci. 31, 12992\u201313001 (2011).","journal-title":"J. Neurosci."},{"key":"408_CR28","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1172\/JCI59643","volume":"122","author":"A Sica","year":"2012","unstructured":"Sica, A. & Mantovani, A. Macrophage plasticity and polarization: in vivo veritas. J. Clin. Invest. 122, 787\u2013795 (2012).","journal-title":"J. Clin. Invest."},{"key":"408_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11499","volume":"7","author":"G Szalay","year":"2016","unstructured":"Szalay, G. et al. Microglia protect against brain injury and their selective elimination dysregulates neuronal network activity after stroke. Nat. Commun. 7, 11499 (2016).","journal-title":"Nat. Commun."},{"key":"408_CR30","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1177\/0271678X17694185","volume":"37","author":"WN Jin","year":"2017","unstructured":"Jin, W. N. et al. Depletion of microglia exacerbates postischemic inflammation and brain injury. J. Cereb. Blood Flow Metab. 37, 2224\u20132236 (2017).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"408_CR31","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3389\/fncel.2016.00286","volume":"10","author":"N Hellstrom Erkenstam","year":"2016","unstructured":"Hellstrom Erkenstam, N. et al. Temporal characterization of microglia\/macrophage phenotypes in a mouse model of neonatal hypoxic-ischemic brain injury. Front. Cell Neurosci. 10, 286 (2016).","journal-title":"Front. Cell. Neurosci."},{"key":"408_CR32","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1093\/jac\/dkn007","volume":"61","author":"BS Murphy","year":"2008","unstructured":"Murphy, B. S. et al. Azithromycin alters macrophage phenotype. J. Antimicrob. Chemother. 61, 554\u2013560 (2008).","journal-title":"J. Antimicrob. Chemother."},{"key":"408_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-015-0440-3","volume":"12","author":"B Zhang","year":"2015","unstructured":"Zhang, B. et al. Azithromycin drives alternative macrophage activation and improves recovery and tissue sparing in contusion spinal cord injury. J. Neuroinflamm. 12, 218 (2015).","journal-title":"J. Neuroinflamm."},{"key":"408_CR34","doi-asserted-by":"publisher","first-page":"F250","DOI":"10.1136\/archdischild-2017-312744","volume":"103","author":"CJ Tann","year":"2018","unstructured":"Tann, C. J. et al. Perinatal risk factors for neonatal encephalopathy: an unmatched case-control study. Arch. Dis. Child Fetal Neonatal Ed. 103, F250\u2013F256 (2018).","journal-title":"Arch. Dis. Child Fetal Neonatal Ed."},{"key":"408_CR35","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jpeds.2018.08.028","volume":"203","author":"SJ Parker","year":"2018","unstructured":"Parker, S. J., Kuzniewicz, M., Niki, H. & Wu, Y. W. Antenatal and intrapartum risk factors for hypoxic-ischemic encephalopathy in a US birth cohort. J. Pediatr. 203, 163\u2013169 (2018).","journal-title":"J. Pediatr."},{"key":"408_CR36","unstructured":"2013 FDA Drug Safety Communication: Azithromycin (Zithromax or Zmax) and the risk of potentially fatal heart rhythms. U.S. Food & Drug Administration, \n                    www.fda.gov\n                    \n                  ."},{"key":"408_CR37","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1542\/peds.111.2.244","volume":"111","author":"MR Battin","year":"2003","unstructured":"Battin, M. R., Penrice, J., Gunn, T. R. & Gunn, A. J. Treatment of term infants with head cooling and mild systemic hypothermia (35.0 degrees C and 34.5 degrees C) after perinatal asphyxia. Pediatrics 111, 244\u2013251 (2003).","journal-title":"Pediatrics"},{"key":"408_CR38","doi-asserted-by":"publisher","first-page":"e0173006","DOI":"10.1371\/journal.pone.0173006","volume":"12","author":"W Zhang","year":"2017","unstructured":"Zhang, W. et al. Therapeutic hypothermia increases the risk of cardiac arrhythmia for perinatal hypoxic ischaemic encephalopathy: a meta-analysis. PLoS ONE 12, e0173006 (2017).","journal-title":"PLoS ONE"},{"key":"408_CR39","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/ana.10242","volume":"52","author":"KL Arvin","year":"2002","unstructured":"Arvin, K. L. et al. Minocycline markedly protects the neonatal brain against hypoxic-ischemic injury. Ann. Neurol. 52, 54\u201361 (2002).","journal-title":"Ann. Neurol."},{"key":"408_CR40","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.expneurol.2004.01.011","volume":"189","author":"M Tsuji","year":"2004","unstructured":"Tsuji, M., Wilson, M. A., Lange, M. S. & Johnston, M. V. Minocycline worsens hypoxic-ischemic brain injury in a neonatal mouse model. Exp. Neurol. 189, 58\u201365 (2004).","journal-title":"Exp. Neurol."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41390-019-0408-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41390-019-0408-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41390-019-0408-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:26:32Z","timestamp":1684603592000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-019-0408-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,17]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["408"],"URL":"https:\/\/doi.org\/10.1038\/s41390-019-0408-6","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,17]]},"assertion":[{"value":"10 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}